128 related articles for article (PubMed ID: 27720715)
1. miR-216b suppresses breast cancer growth and metastasis by targeting SDCBP.
Jana S; Sengupta S; Biswas S; Chatterjee A; Roy H; Bhattacharyya A
Biochem Biophys Res Commun; 2017 Jan; 482(1):126-133. PubMed ID: 27720715
[TBL] [Abstract][Full Text] [Related]
2. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-23a inhibits melanoma cell proliferation, migration, and invasion in mice through a negative feedback regulation of sdcbp and the MAPK/ERK signaling pathway.
Lu S; Xu Q
IUBMB Life; 2019 May; 71(5):587-600. PubMed ID: 30589231
[TBL] [Abstract][Full Text] [Related]
4. Syntenin Regulated by miR-216b Promotes Cancer Progression in Pancreatic Cancer.
Zu F; Chen H; Liu Q; Zang H; Li Z; Tan X
Front Oncol; 2022; 12():790788. PubMed ID: 35155233
[TBL] [Abstract][Full Text] [Related]
5. Repression of miR-135b-5p promotes metastasis of early-stage breast cancer by regulating downstream target SDCBP.
Pu T; Shen M; Li S; Yang L; Gao H; Xiao L; Zhong X; Zheng H; Liu Y; Ye F; Bu H
Lab Invest; 2019 Sep; 99(9):1296-1308. PubMed ID: 31024042
[TBL] [Abstract][Full Text] [Related]
6. microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.
Sun M; Wang X; Tu C; Wang S; Qu J; Xiao S
Cell Biol Int; 2017 Dec; 41(12):1272-1282. PubMed ID: 28225180
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the P2X7R by microRNA-216b in human breast cancer.
Zheng L; Zhang X; Yang F; Zhu J; Zhou P; Yu F; Hou L; Xiao L; He Q; Wang B
Biochem Biophys Res Commun; 2014 Sep; 452(1):197-204. PubMed ID: 25078617
[TBL] [Abstract][Full Text] [Related]
8. miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1.
Zhang G; Liu Z; Xu H; Yang Q
Biochem Biophys Res Commun; 2016 Jan; 469(2):189-95. PubMed ID: 26631969
[TBL] [Abstract][Full Text] [Related]
9. [miR-216b suppresses cell proliferation and invasion by targeting PKCα in nasopharyngeal carcinoma cells].
Deng M; Liu JF; Gu YX; Zheng GP; He ZM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):645-50. PubMed ID: 24332049
[TBL] [Abstract][Full Text] [Related]
10. MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway.
Liu FY; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Wu ZB; Huang ZY; Chen XP
Cell Death Dis; 2015 Mar; 6(3):e1670. PubMed ID: 25741595
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-216b regulates cell proliferation, invasion and cycle progression via interaction with cyclin T2 in gastric cancer.
Chen X; Zhang L; Song Q; Chen Z
Anticancer Drugs; 2020 Jul; 31(6):623-631. PubMed ID: 32058347
[TBL] [Abstract][Full Text] [Related]
12. miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.
Hu JY; Yi W; Wei X; Zhang MY; Xu R; Zeng LS; Huang ZJ; Chen JS
Biomed Pharmacother; 2016 Apr; 79():247-53. PubMed ID: 27044835
[TBL] [Abstract][Full Text] [Related]
13. miR-135a-5p and miR-124-3p Inhibit Malignancy of Glioblastoma by Downregulation of Syndecan Binding Protein.
Lin J; Wen X; Zhang X; Sun X; Yunzhi L; Peng R; Zhu M; Wang M; Zhang Y; Luo W; Luo G; Zhang Y
J Biomed Nanotechnol; 2018 Jul; 14(7):1317-1329. PubMed ID: 29944105
[TBL] [Abstract][Full Text] [Related]
14. miR-216b promotes cell growth and enhances chemosensitivity of colorectal cancer by suppressing PDZ-binding kinase.
Zou J; Kuang W; Hu J; Rao H
Biochem Biophys Res Commun; 2017 Jun; 488(2):247-252. PubMed ID: 28373071
[TBL] [Abstract][Full Text] [Related]
15. Syndecan binding protein (SDCBP) is overexpressed in estrogen receptor negative breast cancers, and is a potential promoter for tumor proliferation.
Qian XL; Li YQ; Yu B; Gu F; Liu FF; Li WD; Zhang XM; Fu L
PLoS One; 2013; 8(3):e60046. PubMed ID: 23533663
[TBL] [Abstract][Full Text] [Related]
16. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
18. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
19. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-216b reduces growth, migration and invasion of pancreatic ductal adenocarcinoma cells by directly targeting ρ-associated coiled-coil containing protein kinase 1.
Liu YA; Zhang Y; Zheng Z; Li K; Wu XH; Du QG; Ye X; Wang L; Zhu L
Oncol Lett; 2018 May; 15(5):6745-6751. PubMed ID: 29616134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
